Cristina A Tan Hehir

Title: Cristina A Tan Hehir: Innovator in Peptide Technology

Introduction

Cristina A Tan Hehir is a prominent inventor based in Niskayuna, NY (US). She has made significant contributions to the field of peptide technology, particularly in the modulation of serum IgG levels. With a total of 2 patents, her work has implications for treating autoimmune diseases and inflammatory disorders.

Latest Patents

One of her latest patents involves peptides that block the binding of IgG to FcRn. This invention relates to peptides that bind to human FcRn and inhibit the binding of the Fc portion of an IgG to FcRn. By doing so, it modulates serum IgG levels, which can be crucial in managing various health conditions. The disclosed compositions and methods may be utilized in treating autoimmune diseases and inflammatory disorders. Additionally, the invention encompasses methods of using and making these peptides.

Career Highlights

Cristina has worked with notable companies in the pharmaceutical industry, including Syntonix Pharmaceuticals, Inc. and Biogen Idec Hemophilia Inc. Her experience in these organizations has contributed to her expertise in peptide technology and innovation.

Collaborations

Some of her coworkers include Adam Robert Mezo and Kevin McDonnell. Their collaboration has likely fostered a productive environment for research and development in their respective fields.

Conclusion

Cristina A Tan Hehir stands out as an innovative inventor whose work in peptide technology has the potential to impact the treatment of autoimmune diseases and inflammatory disorders. Her contributions to the field are noteworthy and continue to inspire advancements in medical science.